differentiation, patent protection as benefits for pharmaceutical companies. But there are some challenges for formulation development studies like taste-masking, disintegration time, moisture sensitivity, friability…
nanodimension changes their physical properties which were used in pharmaceutics to develop a new innovative formulation principle for poorly soluble drugs: The drug nanocrystals. The purpose of this research
controlled based on process parameters. The effect of changes in the equipment, scale, or formulation is typically assessed on the attributes of dried granules or compressed tablets. This approach increases ... role of…
solid lipid nanoparticles (SLNs) in oral delivery of low molecular weight heparin (LMWH). The developed systems were characterized for surface morphology, size and size distribution, zeta potential, entrapment…
delivery oftargeted molecules to an endogenous cholesterol carrier (LDL). Methods:An ultracentrifugation method was developed to separate liposomes from low-densitylipoprotein (LDL).Factors such as density gradient and…
capable of targeting neoplastic cells is highly desired. Our research aimed to develop sustained-release microencapsulated drug formulations using spray drying as a platform technology for the delivery of…
accepted standard for the treatment of pulmonary disease for decades. Recently however, the development of a simple, cost-effective oral inhalation system has opened this route of administration ... pulmonary…
mgcm-2h-1 respectively) for gabapentin when compared to o/w formulations (10.9?1.2 mgcm-2h-1and 9.3?2.1 mgcm-2h-1 respectively). The FTIR results suggest the mechanism ... microemulsion type respectively, can be…
heat burn and nausea when taken orally. The purpose of present investigation was to develop ethosomes containing naproxen, which was incorporated in gel for transdermal delivery of naproxen for systemic ... side effects…
bioavailability from conventional dosage forms. The object of the study was to develop an optimized controlled release floating microspheres of furosemide capable of floating on the gastric fluid releasing…
present investigation is to develop ethosomes loaded with finasteride, which was incorporated within a gel for transdermal delivery for systemic effect in order to avoid side effects and minimize frequency ... used in…
study was aimed to design and develop gastroretentive drug delivery system combining two techniques mucoadhesion and floating. The final formulation was bilayer tablet comprising quetiapine fumarate as a model poorly…
analysis (p<0.001), further confirming the efficacy, safety and biocompatibility of formulation. Thus, the developed formulation based on dual attack on cancerous tissue could prove a promising strategy to treat
hydrolytic degradation in salivary pH. The aim of the present study was to develop buccal mucoadhesive tablets of cur with accepted release and stability at salivary pH as well ... which sodium lauryl sulfate (SLS)…
following oral administration is very low. Hence, it is concrete reason to develop a controlled release formulation of omeprazole. Introduction: Omeprazole is used in a number of acid peptic ulcers
Objectives: The objective is to develop transferrin coupled biodegradable nanoparticles (NPs) contaning pH sensitive fusogenic endosomolytic peptide added to enhance the endosomal lysis that will further potentiate the…
Evaluation of the optimized formulation showed excellent granule and tablet properties. In conclusion, this study has come up with an optimum formula for the development of floating tablet of salbutamol
these agents represents a major obstacle to their development as pharmaceutical productsproducts. We have developed a non-toxic water-in-oil microemulsion technology, called Aonys?, for the delivery of such ... rectal…
present work was to formulate and evaluate the Nisoldipine as Self Nano Emulsifying Drug Delivery System (SNEDDS). Nisoldipine, a calcium channel blocker is used in the treatment of hypertension. Nisoldipine ... highest…
study was aimed to develop a sustained release formulation of diclofenac sodium (DFS) using ethyl cellulose (EC) as retardant through microencapsulation-coacervation and its In-vitro & In-vivo evaluation. Three
objective of this study was to develop compression coated tablets (CCT) of terbutaline sulphate (TBS) microsponges for potential colonic drug delivery with improved gastric resistance and pulsatile release based…
accurate measurement of the swelling profile of such materials remains challenging in pharmaceutical formulation and development. The objective of this study was to investigate the use of a mechanical tester ... single…